Advisory Board Members
Spokeswoman, Summit Advisory Board & Co-Head, IOME
Ida Beerhalter is Co-Head of IOME, a private investment partnership of women principals from the Gulf region with its head office in Riyadh, KSA.
Additionally, Mrs Beerhalter also serves as Member of the Board, Trustee, Advisor and Expert to various for-profit and not-for-profit organizations around the globe (amongst others Astia USA, Auma Obama Foundation Sauti Kuu Germany & Kenya, Omnia Strategy UK, First Light Trust UK, WIP — Women in Parliaments Global Forum Switzerland, slavefreetrade.org Switzerland, Yunus Social Business GmbH Germany, Social Business Earth Switzerland, TBLI Group The Netherlands, Charité Foundation Summit Germany). She is specialized in a wide range of issues including, social business, entrepreneurship, impact investment, gender inclusiveness, women empowerment, investment in emerging markets and wealth management, family governance and succession planning.
Senior Vice President, Business Development, Cooley
Charlie Cameron has over 25 years of business development, investing and management consulting experience in more than 30 countries. His experience ranges from working on strategy with Fortune 500 companies, to counseling emerging technology and life science companies, to venture investing. In addition, he mentors emerging companies, judges numerous business plan competitions and is a frequent speaker on innovation and entrepreneurship. He founded the Hub Angel Investment Group, which is on its fifth fund. He works with a plethora of entrepreneurs, innovators and investors in Europe, with special focus on DACH countries. Charlie is also Senior VP of Strategy at Cooley LLP, a global law firm with deep experience working with life science and tech companies and venture funds. He is on the board of the German American Business Council, Boston, the advisory board of the German Accelerator Life Science, and several other boards and advisory groups. During the past decade, Charlie has built a global network of entrepreneurs, investors, innovators, and others. He is a frequent speaker on panels and at forums related to venture capital and entrepreneurship. He has an MBA from MIT, an MPH from Harvard University, and a BA, Economics-honors, Phi Beta Kappa, from the University of Massachusetts.
Craig Curtis Garner
Group Leader, German Center for Neurodegenerative Diseases, Charité
Craig Curtis Garner
Prof. Craig Garner received his doctoral degree in Biochemistry at Purdue University and did his postdoctoral studies at the Friedrich Miescher Institute in Basel, CH and was a junior group leader at the Center for Molecular Neurobiology in Hamburg. His most recent faculty appointment was at Stanford University as Professor in the Department of Psychiatry and Behavioral Science, where he co-directed the Stanford Down syndrome Center. In 2014, he became a Scientist/co-Speaker of the DZNE-Berlin: German Center for Neurodegenerative diseases and Professor at the Charité –Universitätsmedizin Berlin. In 2015, he co-founded SPARK-Berlin to help educate academic scholars about translation and entrepreneurship. He has also founded three biotech companies, “Balance Therapeutics”, “Stealth Biosciences” and Navan Technologies. He maintains an active basic research program focused on the molecular and physiological mechanisms of synapse assembly and function in health and neurodegenerative diseases.
Executive Director International, Ludwig Fresenius University
Dr. Joann Halpern was the founding director of the German Center for Research and Innovation (GCRI) and an adjunct professor of international education at New York University. GCRI, a joint initiative of Germany’s Federal Foreign Office and the Federal Ministry of Education and Research, was created as a cornerstone of the German government’s initiative to internationalize science and research. Before she joined the GCRI, Dr. Halpern was director of academic affairs at Global College of Long Island University and from 1996-2001 she was director of international programs at Harz University in Wernigerode, Germany. She also co-founded Knowledge Transfer Beyond Boundaries, an NGO with projects in Cameroon, Nigeria, Yemen, and Antigua. Halpern received her B.A. from Dartmouth College, her M.A. from Harvard University, and her Ph.D. from New York University. She is a recipient of the Harvard University Award for Distinction in Teaching as well as fellowships from the Fulbright Commission, the National Endowment for the Humanities, the Robert Bosch Foundation, and the German Academic Exchange Service. She serves on the advisory boards of the German Accelerator, Technical University of Dortmund, Charité Entrepreneurship Summit, University Alliance Ruhr, LIU Global and INet NYC.
Founder, eXXclaim Capital and EILSF
Anula Jayasuriya is an experienced health care and Life Sciences executive and investor. Anula’s expertise consists of a unique combination of business, basic science and medical knowledge.
Recognizing the growing yet under-invested opportunity in Women’s Health, in 2013 Anula launched eXXclaim Capital, focused on catalyzing innovation, entrepreneurship and investment in this field and has already made several investments. In 2006 Anula co-founded the “Evolvence India Life Science Fund” (EILSF), to make investments in pharmaceutical, biotechnology, medical device and contract services companies based in India. EILSF has garnered three successful exits to date and India Life Science 11 has had its first close.
She was previously a partner with Skyline Ventures in Palo Alto, and prior to that with the German – US venture capital firm TVM, in San Francisco. Her prior positions include VP-Corporate development at Genomics Collaborative Inc., and Vice President, Global Drug Development at Hoffman-La Roche for opportunistic infections in AIDS and Transplantation. Anula received a BA from Harvard summa cum laude, and an MD and PhD (in Microbiology and Molecular Genetics) from Harvard Medical School. She interned in Pediatrics at Boston Children’s Hospital and received an MBA with distinction from Harvard Business School. Anula also has a M. Phil. in pharmacology from the University of Cambridge, in England. Anula sits on the boards of Ocimum BioSolutions, and MapMyGenome, Hyderabad and nVision, San Francisco. She was previously a board member of Health Care Global which was exited to Temasek, Lipomics which was acquired by Tethys and Triesta BioSciences which was acquired by Health Care Global. She also serves on several non-profit boards, including Astia, EPPIC, and The Gruter Institute for Law and Behavioral Research.
Co-Founder & Managing Partner, Flying Health Incubator
Markus Müschenich is a board certified pediatrician and has a degree in Public Health. He is the founder of ConceptHealth, a think tank with longterm expertise in strategic business development based on health care's future foresight analysis. After more than ten years membership of executive boards in private and nonprofit hospital companies, Dr. Müschenich co-founded FLYING HEALTH a German company builder and business developer for health startups. FLYING HEALTH partners with founders, connects geeks and healthcare professionals and supports R&D for innovative products and services gaining market access. Dr. Müschenich is member of the board of directors of the German Association for Internet Medicine.
Head of Strategy & Operations, German Accelerator Life Sciences
Through various roles in the German and the US healthcare industries, Annika has extensive experience building strong global networks by bringing together investors, entrepreneurs, and senior industry executives. In her current role as Head of Strategy & Operations at the German Accelerator Life Sciences (GALS), she works with startups and emerging companies from Germany that focus on life sciences and facilitates their successful US market entry. Prior to joining GALS in Cambridge, MA, Annika headed the innovation and entrepreneurship programs of Stiftung Charité in Berlin. Annika has served as advisor and mentor to many startups through groups such as Astia, SPARK, and MIT Hacking Medicine.
Co-Founder, Peppermint VenturePartners
Joachim Rautter is a co-founder of Peppermint VenturePartners and Managing Partner of Peppermint Charité Biomedical Fund.
Prior to the launch of Peppermint VenturePartners, he was Investment Director at Peppermint Holding GmbH. There he was responsible for the investment activities of the Peppermint Venture Capital Fund. He has over 15 years of experience in the venture capital industry and was Chairman of the Supervisory Board of Scienion AG, as well as Chairman of the Advisory Board of JADO Technologies GmbH and Innolume GmbH. He is currently Chairman of the Board of CEVEC Pharmaceuticals GmbH and CellAct Pharma GmbH, and also serves on the Board of CryoTherapeutics GmbH and Labfolder GmbH.
Prior to joining Peppermint, he guided innovative start-ups in the field of start-up financing and entrepreneurial development. In addition, he was involved in key functions in the design and implementation of regional innovation strategies.
Joachim Rautter has a degree in physics and completed his PhD at the Max Volmer Institute for Biophysical Chemistry at the Technical University of Berlin.
Marie M. Warburg
Co-Founder & Director, ACLIRES Holding
Marie M. Warburg
Marie M. Warburg, M.D. received her medical degree from Cornell University Medical College and completed her post-doctoral training in internal medicine at Beth Israel Hospital in Boston. She served as staff physician and chief of Ambulatory Care at Lawrence Memorial Hospital in Medford, Massachusetts and as Senior Medical Director for PAREXEL International, a major global contract research organization before joining Bellevue Asset Management, where she was a portfolio manager for BB Biotech. Since then she has served as a fund manager and consultant for several companies and funds specializing in the biomedical industry, as a director of MPM Capital, Idenix Pharmaceuticals and from 2004-2011 as a managing partner of Private Life Biomed AG, a private equity life science fund. Dr. Warburg is a co-founder and director of ACLIRES Holding Ltd., a Bermuda based contract research organization with a unit in Bangkok, Thailand. She also serves as a board member of the American Council on Germany, the German and American Friends of the Jewish Museum Berlin, Human Rights Watch, the Roland Berger Foundation Kuratorium, and is Chair of several Hamburg based foundations. Dr. Warburg is a consultant to The Medicines Company, a U.S. based biopharmaceutical company.